Cognitive Development is a prestigious academic journal published by Elsevier Science Inc, focusing on the critical area of developmental and cognitive psychology. With an ISSN of 0885-2014 and an E-ISSN of 1879-226X, this journal serves as a vital platform for the dissemination of innovative research, theories, and methodologies from 1986 to the present, with the latest articles contributing to a comprehensive understanding of cognitive processes in children and adolescents. Positioned in the second quartile (Q2) of both the Developmental and Educational Psychology and Experimental and Cognitive Psychology categories, Cognitive Development holds an essential place in shaping contemporary psychological research, boasting robust Scopus rankings of #175/360 and #90/165 in its respective fields. Though not an open-access journal, it provides valuable insights and rigorous studies essential for researchers, professionals, and students engaged in the intricate processes of cognitive development. Whether you're looking to publish significant findings or simply stay updated on the latest advancements, Cognitive Development is an indispensable resource in the psychological community.

Advances in Autism is a prominent academic journal published by Emerald Group Publishing Ltd, dedicated to the comprehensive exploration of autism spectrum disorders through the lenses of Cognitive Neuroscience, Developmental Psychology, and Psychiatry and Mental Health. Since its inception in 2015, the journal has made significant strides in disseminating high-quality research and fostering interdisciplinary collaboration within its diverse scope. With a respectable 2023 impact factor placing it in the Q3 category across multiple relevant fields, including Neurology and Clinical Psychiatry, Advances in Autism serves as an essential resource for researchers, practitioners, and students alike, aiming to advance the understanding of autism and its related challenges. Although currently not open access, the journal provides various subscription options to facilitate widespread access to its cutting-edge insights and empirical studies, making it an indispensable tool for anyone invested in autism research.

AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY is a premier publication in the fields of speech-language pathology, linguistics, and related health professions, published by the American Speech-Language-Hearing Association. With an impressive scope that encompasses research, clinical practice, and education, the journal aims to advance knowledge and practices in the diagnosis, treatment, and prevention of communication and swallowing disorders. It holds notable rankings in 2023, including Q2 in Developmental and Educational Psychology and Q1 across key categories such as Linguistics and Language, Medicine (Miscellaneous), Otorhinolaryngology, and Speech and Hearing, reflecting its significant impact and relevance in these domains. The journal’s robust methodology and peer-reviewed articles serve as an essential resource for researchers, practitioners, and students alike, fostering innovation and collaboration within the field. Published continuously since 1996, it provides a platform for disseminating groundbreaking research that influences clinical practices and educational strategies, enhancing the quality of care for individuals with speech and language challenges.

CoDAS, an esteemed academic journal published by the SOC BRASILEIRA FONOAUDIOLOGIA, serves as a leading platform for interdisciplinary research within the realms of linguistics, speech, and hearing sciences. Established as an Open Access journal in 2013, it ensures broad dissemination and accessibility of scholarly work, significantly benefitting researchers, clinicians, and students alike. Based in Brazil, CoDAS has garnered credibility with its impressive Q2 ranking in Linguistics and Language, as well as its rankings in Otorhinolaryngology and Speech and Hearing categories, reflecting its substantial contribution to these fields. The journal's impact is underscored by its robust Scopus rankings, including the 67th percentile in Language and Linguistics. With a commitment to fostering innovative research and bridging gaps between theory and practice, CoDAS continues to play a vital role in advancing knowledge and clinical practices in communication disorders and auditory sciences.

Analysis of Verbal Behavior is a premier academic journal dedicated to advancing the understanding of verbal behavior and its applications within various disciplines, including psychology, linguistics, and education. Published by Springer, a prominent name in scholarly publishing, this journal serves as a vital resource for researchers, professionals, and students alike. With an ISSN of 0889-9401 and an E-ISSN of 2196-8926, it is accessible through traditional subscriptions, further enhancing its reach among the academic community. The journal is committed to disseminating high-quality research, including empirical studies, theoretical analyses, and practical applications, thereby contributing significantly to the field of behavior analysis. Scholars looking to stay current on the latest developments and methodologies in verbal behavior will find Analysis of Verbal Behavior essential for their professional and academic pursuits.

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, published by Springer/Plenum Publishers, is a premier academic journal dedicated to advancing knowledge in the field of autism and related developmental disorders. With an impressive impact factor reflecting its reputation for rigorous peer-reviewed research, this journal has firmly established itself within the Q1 category of Developmental and Educational Psychology, ranked #32 out of 360 journals in its category, placing it in the top 91st percentile. The journal covers a broad range of topics, including intervention strategies, developmental trajectories, and the neurobiology behind autism spectrum disorders, making it an essential resource for researchers, educators, and clinicians alike. Since its inception in 1979, the journal has maintained a commitment to disseminating significant findings that can contribute to better understanding and support for individuals with developmental disorders, promoting interdisciplinary dialogue and collaboration. While it is not offered as open access, the Journal of Autism and Developmental Disorders remains a vital platform for the dissemination of transformative research in this crucial area.

Autism Research, published by WILEY, is a premier academic journal dedicated to advancing the understanding of autism spectrum disorders (ASD) through high-quality research and clinical studies. With the ISSN 1939-3792 and E-ISSN 1939-3806, this journal has been integral to the field since its inception in 2008 and has been consistently ranked in the Q1 quartile across categories such as Genetics (clinical), Neurology (clinical), and various facets of Neuroscience. Holding prominent Scopus ranks, including #18 in Genetics (clinical) and #26 in General Neuroscience, Autism Research provides a vital platform for researchers, clinicians, and students alike to disseminate innovative findings and foster collaborations aimed at improving diagnosis and treatment strategies for individuals with autism. While not an open access journal, it offers a blend of insightful articles and impactful research that is essential for professionals seeking to stay at the forefront of this rapidly evolving field.

BEHAVIOR MODIFICATION, published by SAGE PUBLICATIONS INC, is a prestigious journal dedicated to advancing the study and practice of behavior modification across various disciplines. With a robust ISSN of 0145-4455 and an E-ISSN of 1552-4167, this journal has established itself as a vital resource for researchers and practitioners since its inception in 1977. Recognized for its academic rigor, it is classified in the Q1 quartile for Arts and Humanities and Q2 in Clinical Psychology, as well as Developmental and Educational Psychology for 2023, showcasing its influence and relevance in these fields. The journal's Scopus rankings further exhibit its high standing, with 90th percentile in Arts and Humanities and 75th percentile in both development and clinical psychology categories. Although it is not an open-access journal, it provides essential insights and comprehensive research aimed at promoting evidence-based practices and innovative interventions in behavior modification. With a commitment to fostering interdisciplinary collaboration, BEHAVIOR MODIFICATION serves as an essential platform for researchers, professionals, and students seeking to enhance their understanding of behavioral principles to impact individual lives positively.

The INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE is a critical platform for disseminating cutting-edge research in the field of developmental biology and neuroscience. Published by WILEY, this esteemed journal has been contributing to the academic community since its inception in 1983, and continues to serve as a vital resource through to 2024. With an impact factor that reflects its influence in the field—ranking in Q3 for both Developmental Biology and Developmental Neuroscience—this journal presents an opportunity for researchers, professionals, and students alike to engage with pioneering studies and extend their understanding of complex developmental processes. Although not open access, the journal provides an essential repository of knowledge for those seeking to explore the nuances of neurological development and related disciplines. It actively supports academic discourse and research dissemination, thereby playing a significant role in advancing our collective understanding of developmental neuroscience.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.